Featured Research

from universities, journals, and other organizations

Gene Find Raises Hopes Of New Treatment For Bowel Cancer

Date:
May 6, 2003
Source:
Cardiff University
Summary:
A significant breakthrough by scientists at Cardiff University and the University of Edinburgh will enable new drugs to be developed, which could prevent bowel cancer.

A significant breakthrough by scientists at Cardiff University and the University of Edinburgh will enable new drugs to be developed, which could prevent bowel cancer.

Researchers led by Professor Adrian Bird at Edinburgh and Professor Alan Clarke at Cardiff have discovered a gene, called MBD2, which is essential for bowel cancer cells to grow, but is dispensable in normal cells. The findings of the research, funded in part by the Wellcome Trust and published in the journal Nature Genetics, raise the possibility that drugs which inactivate MBD2 could prevent human bowel cancer without harming normal cells. Bowel cancer is the UK's second most common cause of cancer death, after lung cancer.

Cancer is caused by cells that escape the body's controls and multiply aggressively to make a tumour. Most anti-tumour therapies attack these multiplying cells, but in doing so they also kill normal cells, such as skin cells and blood that must be able to multiply in any healthy person.

The new findings show that MBD2 is needed much more by tumour cells than by healthy cells and may therefore represent a medical Achilles' heel for this type of cancer. As yet there are no anti-MBD2 drugs, but there is now a strong case for developing them as potential anti-cancer agents.

Professor Clarke, of Cardiff University's School of Biosciences, said: "Our research provides a significant breakthrough in understanding the pathways that can lead to bowel cancer. Cancer is primarily caused by irrevocable alterations to genes, called mutations. Recent work has revealed, however, that some key genes in cancer cells are altered in more subtle ways that are potentially reversible.

"The new findings reinforce this idea, as MBD2 is known to silence genes that have no mutations in them. It now seems that colorectal cancer depends on this kind of gene silencing, whereas normal tissues can remain healthy without it. The exciting possibility is therefore that colon cancer will be treatable by drugs that interfere with the gene silencing process by targeting MBD2."


Story Source:

The above story is based on materials provided by Cardiff University. Note: Materials may be edited for content and length.


Cite This Page:

Cardiff University. "Gene Find Raises Hopes Of New Treatment For Bowel Cancer." ScienceDaily. ScienceDaily, 6 May 2003. <www.sciencedaily.com/releases/2003/05/030506073520.htm>.
Cardiff University. (2003, May 6). Gene Find Raises Hopes Of New Treatment For Bowel Cancer. ScienceDaily. Retrieved August 22, 2014 from www.sciencedaily.com/releases/2003/05/030506073520.htm
Cardiff University. "Gene Find Raises Hopes Of New Treatment For Bowel Cancer." ScienceDaily. www.sciencedaily.com/releases/2003/05/030506073520.htm (accessed August 22, 2014).

Share This




More Health & Medicine News

Friday, August 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Drug Used To Treat 'Ebola's Cousin' Shows Promise

Drug Used To Treat 'Ebola's Cousin' Shows Promise

Newsy (Aug. 21, 2014) An experimental drug used to treat Marburg virus in rhesus monkeys could give new insight into a similar treatment for Ebola. Video provided by Newsy
Powered by NewsLook.com
Two US Ebola Patients Leave Hospital Free of the Disease

Two US Ebola Patients Leave Hospital Free of the Disease

AFP (Aug. 21, 2014) Two American missionaries who were sickened with Ebola while working in Liberia and were treated with an experimental drug are doing better and have left the hospital, doctors say on August 21, 2014. Duration: 01:05 Video provided by AFP
Powered by NewsLook.com
Cadavers, a Teen, and a Medical School Dream

Cadavers, a Teen, and a Medical School Dream

AP (Aug. 21, 2014) Contains graphic content. He's only 17. But Johntrell Bowles has wanted to be a doctor from a young age, despite the odds against him. He was recently the youngest participant in a cadaver program at the Indiana University NW medical school. (Aug. 21) Video provided by AP
Powered by NewsLook.com
American Ebola Patients Released: What Cured Them?

American Ebola Patients Released: What Cured Them?

Newsy (Aug. 21, 2014) It's unclear whether the American Ebola patients' recoveries can be attributed to an experimental drug or early detection and good medical care. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins